FIELD: research and analysis of materials.
SUBSTANCE: invention relates to methods for analyzing biological materials, namely blood serum. Method for evaluating the effectiveness of inhalation antibiotic therapy for nosocomial pneumonia is to determine the protein content of Clara cells in the serum of venous blood 1 hour before the first inhalation of the antibiotic and 1 hour after inhalation with an enzyme immunoassay, an increase in the protein content of Clara cells at least 1.5 times indicates the effectiveness of inhalation antibacterial therapy.
EFFECT: method for evaluating the effectiveness of inhalation antibiotic therapy is proposed.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING EFFECTIVENESS OF INHALATION ANTIBACTERIAL THERAPY OF HOSPITAL-AQUIRED PNEUMONIA CAUSED BY GRAM-NEGATIVE FLORA | 2011 |
|
RU2456614C1 |
| METHOD FOR PREVENTION OF HEALTHCARE-ASSOCIATED INFECTIONS IN PATIENTS IN CHRONIC CRITICAL CONDITION | 2023 |
|
RU2818910C1 |
| METHOD FOR THE TREATMENT AND PREVENTION OF RECURRENCE OF NOSOCOMIAL PNEUMONIA | 2021 |
|
RU2794585C2 |
| METHOD OF RESPIRATORY DISTRESS-SYNDROME THERAPY IN NEWBORN BABIES WHO ARE ON ARTIFICIAL LUNG VENTILATION | 2010 |
|
RU2434653C1 |
| LABORATORY DIAGNOSTIC TECHNIQUE FOR SEPTIC ENCEPHALOPATHY IN NEWBORNS SUFFERING FROM PERINATAL HYPOXIC INJURY OF CENTRAL NERVOUS SYSTEM | 2012 |
|
RU2519729C1 |
| METHOD FOR LABORATORY ASSESSMENT OF EFFICACY OF ANTIBACTERIAL THERAPY | 2012 |
|
RU2543335C2 |
| METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE OUTCOME FOR PATIENTS IN CHRONIC CRITICAL CONDITION DUE TO CEREBRAL ACCIDENTS COMPLICATED BY PNEUMONIA | 2024 |
|
RU2822966C1 |
| METHOD FOR LABORATORY ASSESSMENT OF EFFECTIVENESS IN TREATMENT OF INTOXICATION IN EMERGENCY PATIENTS | 2012 |
|
RU2522877C2 |
| METHOD FOR DETERMINING SEVERITY OF COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE | 2021 |
|
RU2767892C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF BRONCHIAL ASTHMA PHENOTYPES | 2023 |
|
RU2807381C1 |
